Future Targeted Healthcare Manufacturing Hub
Biomanufacturing solutions to transform healthcare precision in the biotherapeutics sector
UCL Biochemical Engineering has an outstanding track record and is a world leader in bioprocess research across a range of sectors. UCL’s Future Targeted Healthcare Manufacturing Hub engages leading academics across the UK as Spokes. This national asset is valued in excess of £20M over 7 years (2017–2024).
The Hub will address the manufacturing, business and regulatory challenges to ensure that new targeted biological medicines can be developed quickly and manufactured at a cost affordable to society.
The research will span stratified protein medicines targeted to particular patient groups through to truly personalised cell-based medicines.
The Hub is unique in the biomanufacturing space, and is being supported by a large number of the leading manufacturers and suppliers in the biotherapeutics industry and non-governmental associations.
How can stratified proteins and personal cell therapies achieve success in manufacturing and business?
For more information on the Hub, collaboration and how join the industrial consortium please contact: